NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, TO
U.S. NEWS WIRE SERVICES, OR FOR DISSEMINATION IN OR INTO THE UNITED STATES,
AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S
REPUBLIC OF CHINA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION
OR RELEASE WOULD BE UNLAWFUL.

Espoo, Finland, 25 May 2021: Reference is made to the stock exchange release by
Nordhealth AS ("Nordhealth" or the "Company") on 25 May 2021 regarding the
successful completion of a private placement (the "Offering").

Didier Breton, chairman of the board, was allocated 100,000 new shares at NOK
40.786 per share in the Offering. Following completion of the Offering, Didier
Breton will own 100,000 class A shares in the Company, equal to 0.125% ownership
in the Company following the issuance of the new shares in the Offering.

Please refer to the attached notification of trading for further details.

Company in brief: A cloud-based healthcare SaaS company with a purpose

Nordhealth is a cloud-based healthcare SaaS company whose mission is to redefine
digital healthcare. The Company's products empower healthcare professionals to
improve patient care, increase efficiency and expand their business. Since 2005,
the Company has acquired and built cloud-based software for veterinary and
therapeutic professionals and their patients, and now serves more than 30,000
professionals across 7,000 clinics and hospitals located in over 25 countries.
Nordhealth has a solid footprint in the Nordic region and a growing presence
internationally. The Company's highly diversified customer base includes Tier 1
companies such as IVC Evidensia, AniCura, Coronaria, and Fysios. Nordhealth, is
headquartered in Espoo, Finland. The Group is remote-first, with more than 140
employees working either remotely or from offices (collaboration hubs), serving
a global customer base.

Advisers 

Carnegie AS acts as sole bookrunner in respect to the Offering and Listing (the
"Manager"). Advokatfirmaet Thommessen AS acts as legal counsel to the Company
and Advokatfirmaet Haavind AS acts as legal counsel to the Manager. 

For further information, please contact: 

Charles MacBain, CEO 
charles.macbain@nordhealth.com 
+44 75 3903 2200

Valter Pasanen, CFO
valter.pasanen@nordhealth.com
+358 50 560 9286


IMPORTANT NOTICE:

This announcement is not for distribution or release, in whole or in part,
directly or indirectly, in or into the United States of America (including its
territories and possessions, any state of the United States of America and the
District of Columbia) (the "United States"), Australia, Canada, the Hong Kong
Special Administrative Region of the People's Republic of China or Japan, or any
other jurisdiction in which the distribution or release would be unlawful.

This announcement does not constitute or form a part of any offer of securities
for sale or a solicitation of an offer to purchase securities of the Company in
the United States or any other jurisdiction. The securities of the Company may
not be offered or sold in the United States absent registration or an exemption
from registration under the U.S. Securities Act of 1933, as amended (the "U.S.
Securities Act"). The securities of the Company have not been, and will not be,
registered under the U.S. Securities Act, and may not be offered or sold in the
United States absent registration under the US Securities Act or an available
exemption from, or transaction not subject to, the registration requirements of
the US Securities Act. There will be no public offering of securities in the
United States. Any sale in the United States of the securities mentioned in this
communication will be made solely to "qualified institutional buyers" as defined
in Rule 144A under the U.S. Securities Act. No public offering of the securities
will be made in the United States.

The Company has not authorized any offer to the public of securities in any
Member State of the European Economic Area nor elsewhere. With respect to any
Member State of the European Economic Area (each an "EEA Member State"), no
action has been undertaken or will be undertaken to make an offer to the public
of securities requiring publication of a prospectus in any EEA Member State. In
any EEA Member State, this communication is only addressed to and is only
directed at qualified investors in that Member State within the meaning of the
EU Prospectus Regulation, i.e., only to investors who can receive the offer
without an approved prospectus in such EEA Member State. The expression "EU
Prospectus Regulation" means Regulation (EU) 2017/1129 of the European
Parliament and of the Council of 14 June 2017 (together with any applicable
implementing measures in any Member State).

In the United Kingdom, this communication is only addressed to and is only
directed at Qualified Investors who (i) are investment professionals falling
within Article 19(5) of the Financial Services and Markets Act 2000 (Financial
Promotion) Order 2005 (as amended) (the "Order") or (ii) are persons falling
within Article 49(2)(a) to (d) of the Order (high net worth companies,
unincorporated associations, etc.) (all such persons together being referred to
as "Relevant Persons"). These materials are directed only at Relevant Persons
and must not be acted on or relied on by persons who are not Relevant Persons.
Any investment or investment activity to which this announcement relates is
available only to Relevant Persons and will be engaged in only with Relevant
Persons. Persons distributing this communication must satisfy themselves that it
is lawful to do so.

Matters discussed in this announcement may constitute forward-looking
statements. Forward-looking statements are statements that are not historical
facts and may be identified by words such as "anticipate", "believe",
"continue", "estimate", "expect", "intend", "may", "should", "will" and similar
expressions. The forward-looking statements in this release are based upon
various assumptions, many of which are based, in turn, upon further assumptions.
Although the Company believes that these assumptions were reasonable when made,
these assumptions are inherently subject to significant known and unknown risks,
uncertainties, contingencies and other important factors which are difficult or
impossible to predict and are beyond its control. Such risks, uncertainties,
contingencies and other important factors could cause actual events to differ
materially from the expectations expressed or implied in this release by such
forward-looking statements. The information, opinions and forward-looking
statements contained in this announcement speak only as at its date and are
subject to change without notice.

This announcement is made by and, and is the responsibility of, the Company. The
Manager is acting exclusively for the Company and no one else and will not be
responsible to anyone other than the Company for providing the protections
afforded to their respective clients, or for advice in relation to the contents
of this announcement or any of the matters referred to herein. 

Neither the Manager nor any of its respective affiliates makes any
representation as to the accuracy or completeness of this announcement and none
of them accepts any responsibility for the contents of this announcement or any
matters referred to herein.

This announcement is not a prospectus. No prospectus is required and no such
prospectus or similar document will be published in connection with the
Offering. This announcement is for information purposes only and is not to be
relied upon in substitution for the exercise of independent judgment. It is not
intended as investment advice and under no circumstances is it to be used or
considered as an offer to sell, or a solicitation of an offer to buy any
securities or a recommendation to buy or sell any securities of the Company.
Neither the Manager nor any of its respective affiliates accepts any liability
arising from the use of this announcement.

Each of the Company, the Manager and their respective affiliates expressly
disclaims any obligation or undertaking to update, review or revise any
statement contained in this announcement whether as a result of new information,
future developments or otherwise.

The distribution of this announcement and other information may be restricted by
law in certain jurisdictions. Persons into whose possession this announcement or
such other information should come are required to inform themselves about and
to observe any such restrictions.

Click here for more information

© Oslo Bors ASA, source Oslo Stock Exchange